Business Context and Reporting Period
This Form 8-K, dated February 12, 2025, reports the Initial Public Offering (IPO) of SailPoint, Inc. The Company converted from a Delaware limited partnership to a Delaware corporation on February 12, 2025. The IPO closed on February 14, 2025, with common stock (Symbol: SAIL) beginning trading on The Nasdaq Stock Market LLC.
Key Financial Metrics and Transaction Details
The filing details the capital raise structure rather than historical operating performance metrics such as revenue or profit.
- Public Offering Price: $23.00 per share.
- Company Shares Sold: 57,500,000 shares.
- Selling Stockholder Shares: 2,500,000 shares.
- Total Firm Shares: 60,000,000 shares.
- Underwriters' Purchase Price: $21.9075 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 9,000,000 additional shares.
- Underwriters: Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained in the Prospectus filed separately.
Material Changes Versus Prior Period
The primary material change is the Company's transition from a private limited partnership to a public corporation. This filing documents the entry into a material definitive underwriting agreement and the subsequent closing of the IPO, which fundamentally alters the Company's capital structure and public trading status.
Guidance, Outlook, and Corporate Actions
The filing does not contain forward-looking guidance, revenue outlook, or management commentary on future performance. However, it details several corporate governance actions taken in connection with the IPO:
- Corporate Conversion: Filed Certificate of Incorporation and adopted Bylaws effective February 12, 2025.
- Compensation Plans: Adopted the SailPoint, Inc. Omnibus Incentive Plan and Employee Stock Purchase Plan (ESPP).
- Indemnification: Entered into indemnification agreements with all directors and executive officers.
- Director Designation: Entered into a Director Designation Agreement with certain stockholders.
Investor Verification Checklist
- Verify the final number of shares sold, including any exercise of the 9,000,000 share over-allotment option.
- Review the Prospectus (File No. 333-284339) for audited financial statements, revenue trends, and liquidity data not included in this 8-K.
- Confirm the specific terms of the Director Designation Agreement regarding board composition.
- Examine the Omnibus Incentive Plan and ESPP details to understand potential dilution from future equity grants.
- Check for any lock-up agreements or restrictions on the sale of shares by Selling Stockholders.